Rising global prevalence of blood cancers and inherited blood disorders, expanded donor and cord-blood registries, and continuous clinical advances in cell and gene therapies are driving steady momentum across the Hematopoietic Stem Cell Market, with hematopoietic stem cell transplantation benchmarks spanning USD 4.13 billion to USD 5.64 billion in 2026 toward USD 6.83 billion by 2031 (10.55%...